|
⚲
|
| Keyboard |
| Hwang Larn
✚
|
|
|---|---|
| CIK # | 0001697480 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001697480] | |
| 4 | [0001697480] | |
| SC 13D | [0001697480] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Hwang LARN | Mateon Therapeutics Inc | [2019-05-02] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Mateon Therapeutics Inc | |
| Hwang Larn | |
| Adhera Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Adhera Therapeutics Inc MRNA
5% Convertible Promissory Note · derivative
|
2018-04-16 | Conversion | $0.00 | ||
|
Adhera Therapeutics Inc MRNA
Warrants to Purchase Common Stock · derivative
|
2018-04-16 | Conversion | 78,300 | $0.00 | |
|
Adhera Therapeutics Inc MRNA
Series E Convertible Preferred Stock · derivative
|
2018-04-16 | Conversion | 10.44 | $5,000.00 | 52,200 |
|
Adhera Therapeutics Inc MRNA
5% Convertible Promissory Note · derivative
|
2017-06-30 | Grant | $50,000.00 | ||
|
Adhera Therapeutics Inc MRNA
Options to purchase common stock · derivative
|
2017-02-13 | Grant | 60,000 | $0.00 |